CALR loss-of-heterozygosity as a potential driver for extramedullary AML. Weller MC, Haralambieva E, Buhler MM, Benz R, et al. Ann Hematol 2022;101:2571-2573.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Weller MC, Haralambieva E, Buhler MM, Benz R, et al. CALR loss-of-heterozygosity as a potential driver for extramedullary AML. Ann Hematol 2022;101:2571-2573.
PMID: 36155839